1Fritscher-Ravens A, Sriram PV, Krause C, et al. Detection of pancreatic metastases by EUS-guided fine-needle aspiration. Gastrointest Endosc,2001,53:65-70.
2O'Reilly DA, Kingsnorth AN. Hereditary pancreatitis and mutationsof the cationic trypsinogen gene. Br J Surg, 2000,87: 708-717.
3Bhutani MS. Endoscopic ultrasound in pancreatic diseases. Gastroenterol Clin North Am, 1999,28: 747-770.
4O' Toole D, Palazzo L, Arotcarena R, et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc,2001,53:470-474.
5Berberat P, Friess H, Kashiwagi M, et al. Diagnosis and staging ofpancreatic cancer by positron emission tomography. World J Surg,1999,23: 882-887.
6Theodor L, Melzer E, Sologov M, et al. Diagnostic value of K-rasmutations in serum of pancreatic cancer patients. Ann NY Acad Sci,2000,906:19-24.
7Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in purepancreatic juice for the diagnosis of pancreatic cancer may be complementary to K ras mutation. Gastrointest Endosc, 2000, 51: 708-713.
3Ziske C,Schlie C,Gorschlüter M,et al.Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine[J].Br J Cancer,2003,89(8):1414-1417.
4Takhar AS,Palaniappan P,Dhingsa R,et al.Recent developments in diagnosis of pancreatic cancer[J].BMJ,2004,329(7467):668-673.
5Nagahama H, Okada S, Okusaka T, et al. Clinicalpathological features in misdiagnosed pancreatic carcinoma[J]. Hepatogastroenterology, 1999,46(29):2983-2985.
6Banfi G,Zerbi A, Pastori S, et al. Beharior of tumor markers. CA 19 -9,CA195 ,CAM43 ,and TPS in the diagnosis and follow -up of pancreatic cancer. Clin Chem, 1993,39:420 - 423.
7Tian F, Appert HE, Myles J, et al. Prognostic value of serum CA 19 - 9 lerels in pancreatic adenocarcinoma. Ann Surg, 1992,215:350-355.
8Gold EB,Goldin SB.Epidemiology and risk factors for pancreatic cancer[J].Surg Oncol Clin N AM,1998,7(1):67.
9Gold EB.Epidemiology and risk factors in pancreatic cancer[J].Surg Clin North Am,1995,75(5):819.
10Kawarada Y,Yamagisawa K,Isaji S,et al.The prevalence of pancreatic cancer lymph node metastasis in Japan and pancreatic cancer staging categories[J].Int J Pancreatol,1994,16:101.
